Crews Bank & Trust’s AstraZeneca AZN Stock Holding History

Crews Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.3K	Sell	418 -32	-7%	-$6.02K	0.01%	320
2026 Q1	$88.7K	Buy	450 +32	+8%	+$6.17K	0.01%	307
2025 Q4	$76.9K	Hold	418	–	–	0.01%	313
2025 Q3	$64.1K	Hold	418	–	–	0.01%	334
2025 Q2	$58.4K	Hold	418	–	–	0.01%	338
2025 Q1	$61.4K	Hold	418	–	–	0.01%	318
2024 Q4	$54.8K	Buy	+418	New	+$58.5K	0.01%	332

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Crews Bank & Trust's AZN Position: Q2 2026 in Review

Crews Bank & Trust reduced its AstraZeneca (AZN) stake by 7.1% in Q2 2026, selling an estimated $6.02K and leaving 418 shares worth $79.3K. The position accounts for 0.01% of the portfolio, ranked #320.

Crews Bank & Trust first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $88.7K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Crews Bank & Trust held 418 shares of AstraZeneca worth $79.3K as of Q2 2026.
Crews Bank & Trust sold 32 AstraZeneca shares in Q2 2026, an estimated $6.02K.
AstraZeneca made up 0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #320 holding.
Crews Bank & Trust first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
Crews Bank & Trust's AstraZeneca position peaked at $88.7K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.